hexalen
Pharmaranks rates Hexalen 3.5/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Hexalen (Altretamine) is a medication used to treat Ovarian Neoplasms.
Altretamine · by Eisai Inc
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Altretamine
- Form
- Capsule
- Strength
- Altretamine 50MG
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- May treat
- ovarian neoplasms
- Manufacturer
- Eisai Inc
- FDA application
- NDA019926
- Availability
- Discontinued (per FDA)
May treat (source: NIH RxClass)
Dosage forms
Capsule
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Hexalen treat?
- Hexalen (Altretamine) may be used to treat ovarian neoplasms, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How is Hexalen rated?
- pharmaranks gives Hexalen a composite score of 3.5 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- Is there a coupon or discount for Hexalen?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Hexalen. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Hexalen?
- Hexalen is marketed by Eisai Inc. You can see Eisai Inc's full profile, rating, and other products on pharmaranks.
- Is Hexalen a brand-name or generic drug?
- Hexalen is a brand-name product with the active ingredient Altretamine.
- Is Hexalen available over the counter?
- No. Hexalen is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Hexalen come in?
- Hexalen is currently marketed as capsule, per the FDA's National Drug Code Directory.
- Is Hexalen FDA-registered?
- Hexalen is on record with the U.S. FDA under application number NDA019926. You can verify this on its official FDA label.
- Has Hexalen been recalled by the FDA?
- Hexalen has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Hexalen safe?
- There's no single safe-or-not verdict. pharmaranks gives Hexalen a recall-safety score of 70/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about ALTRETAMINE
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 20 reports naming ALTRETAMINE — the active ingredient in Hexalen, and the FDA flagged 90% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- nausea6 reports
- alopecia5 reports
- abdominal distension4 reports
- diarrhoea3 reports
- emotional distress3 reports
- psychological trauma3 reports
- tumour lysis syndrome3 reports
- vomiting3 reports
Read these as a signal, not a rate. A report does not mean ALTRETAMINE caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 25, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
alymsys
Bevacizumab-Maly
avastin
Bevacizumab
eligard kit
Leuprolide Acetate
mvasi
Bevacizumab-Awwb
zejula
Niraparib Tosylate
taxotere
Docetaxel
Compare Hexalen head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
hexalen
70/100